Roger J. Waltzman

3.0k citations
36 papers · 1.8k indexed · 1 hit paper · h-index 12
Topics
Erythropoietin and Anemia Treatment (10 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)Chronic Myeloid Leukemia Treatments (5 papers)
Journals
New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Roger J. Waltzman

36 papers receiving 1.7k citations

Hit Papers

JAK Inhibition with Ruxolitinib versus Best Available The...201220262016202120124008001.2k

Peers

Roger J. Waltzman
Comparison fields: 5 of 70
  • Genetics 1.2k
  • Hematology 1.0k
  • Molecular Biology 658
  • Rheumatology 431
  • Oncology 368
Replace Miklós Egyed with:
Miklós Egyed Hungary
Michael J. Barnett Canada
Jesper Stentoft Denmark
Nathalie Cambier France
Markus Pfirrmann Germany
Aruna Raghavachar Germany
Israel Bendit Brazil
Stefan O. Ciurea United States
Françoise Rigal‐Huguet France
EN Dessypris United States
Roger J. Waltzman relative to Miklós Egyed Hungary Miklós Egyed's profile →
Citations per field
00.5×1.5×2.3×
Miklós Egyed · 1×
Citations per year

Countries citing papers authored by Roger J. Waltzman

Since Specialization
Citations

This map shows the geographic impact of Roger J. Waltzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger J. Waltzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger J. Waltzman more than expected).

Fields of papers citing papers by Roger J. Waltzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger J. Waltzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger J. Waltzman. The network helps show where Roger J. Waltzman may publish in the future.

Co-authorship network of co-authors of Roger J. Waltzman

This figure shows the co-authorship network connecting the top 25 collaborators of Roger J. Waltzman. A scholar is included among the top collaborators of Roger J. Waltzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger J. Waltzman. Roger J. Waltzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 2
4 3
5 7
6 1
7
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosisbreakdown →
1218
8 2
9 22
10 41
11 23
12 1
13 7
14 64
15 19
16 6
17
Managing hematologic toxicities.
8
18 11
19 39
20 88

About Roger J. Waltzman

Roger J. Waltzman is a scholar working on Hematology, Genetics and Biochemistry, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Genetics (1.2k citations), Hematology (1.0k citations) and Rheumatology (431 citations). Roger J. Waltzman has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Deborah Hunter, Giovanni Barosi, Jean‐Jacques Kiladjian, Tiziano Barbui, Claire Harrison, Haifa Kathrin Al‐Ali, Mari McQuitty, Viktoriya Stalbovskaya, Francisco Cervantes and Alessandro M. Vannucchi. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026